Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Al-Siddiq Waqaas

2. Date of Event Requiring Statement (MM/DD/YYYY) 7/16/2019

3. Issuer Name and Ticker or Trading Symbol

BIOTRICITY INC. [BTCY]

(Last) (First) (Middle)

275 SHORELINE DRIVE, SUITE 150

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director ___ X ___ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
CEO and Chairman of the Board /

(Street)

REDWOOD CITY, CA 94065

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	4712336	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options (Right to buy)	⁽¹⁾	⁽¹⁾	Common stock	2499998	$2.20	D
Options (Right to buy)	⁽²⁾	⁽²⁾	Common stock	1300000	$5.44	D

Explanation of Responses:
(1)	Stock options granted in July 2016 pursuant to the 2016 Equity Incentive Plan and vested in equal monthly installments beginning on July 31, 2016. The options expire five years from their vesting date.
(2)	Stock options granted on January 1, 2018 pursuant to the 2016 Equity Incentive Plan. The options began vesting equally in thirty monthly installments on January 31, 2018 and will continue to vest monthly until June 30, 2020. The options expire five years from the date of vesting and, as of the date of this filing, approximately 40% of the options remain unvested.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Al-Siddiq Waqaas 275 SHORELINE DRIVE, SUITE 150 REDWOOD CITY, CA 94065	X	X	CEO and Chairman of the Board

Signatures
/s/ Waqaas Al-Siddiq		8/1/2019
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.